Irene G. Roberts

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

Journal: Blood
Published: February 04, 2026

Vaccination at a crossroad: science, politics and public trust.

Vaccination at a crossroad: science, politics and public trust.

Journal: Swiss medical weekly
Published: October 29, 2025

RPS19 and RPL5 Haploinsufficient Models Reveal Divergent Ribosomal Subunit Controls of Fetal Hematopoiesis.

RPS19 and RPL5 Haploinsufficient Models Reveal Divergent Ribosomal Subunit Controls of Fetal Hematopoiesis.

Journal: Research square
Published: October 03, 2025

RPS19 and RPL5 haploinsufficient models reveal divergent ribosomal subunit controls of fetal hematopoiesis.

RPS19 and RPL5 haploinsufficient models reveal divergent ribosomal subunit controls of fetal hematopoiesis.

Journal: Nature communications
Published: September 11, 2025

Hematological Conditions in Infants With Trisomy 21.

Hematological Conditions in Infants With Trisomy 21.

Journal: NeoReviews
Published: June 18, 2025

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Journal: Blood
Published: March 21, 2025

Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome.

Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome.

Journal: Blood
Published: March 18, 2025

Genome-wide association study of somatic GATA1s mutations in newborns with Down syndrome.

Genome-wide association study of somatic GATA1s mutations in newborns with Down syndrome.

Journal: Blood advances
Published: February 21, 2025

Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Journal: Blood
Published: December 13, 2024

PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.

PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.

Journal: Blood advances
Published: October 29, 2024

Genome-wide association studies of Down syndrome associated congenital heart defects.

Genome-wide association studies of Down syndrome associated congenital heart defects.

Journal: medRxiv : the preprint server for health sciences
Published: September 16, 2024

Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS.

Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS.

Journal: Genetic epidemiology
Published: September 06, 2024
Showing 1-12 of 102

Last Updated: 09/26/2026